Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
The National Cancer Institute (NCI) is establishing a new Cancer Screening Research Network (CSRN). The CSRN will conduct rigorous, multi-center cancer screening trials and related studies with large and diverse populations in a variety of health care settings, with the goal of reducing cancer-related morbidity and mortality. Cancer screening provides a unique opportunity to diagnose cancers and pre-cancerous lesions before symptoms develop. New and emerging technologies, including Multi-Cancer Detection assays (MCDs), are rapidly coming forward for commercial availability but well-conceived randomized controlled trials to evaluate them are lacking. As an initial effort, the CSRN will develop a feasibility study, called a Vanguard study, to inform the design of future large-scale clinical trials to assess a variety of cancer screening modalities.
The network is comprised of Accrual, Enrollment, and Screening Site (ACCESS) Hubs; a Statistics and Data Management Center (SDMC); and a Coordinating and Communication Center (CCC). (See RFA-CA-23-022: NCI Cancer Screening Research Network: Coordinating and Communication Center and RFA-CA-23-021: NCI Cancer Screening Research Network: Statistics and Data Management Center)
We are seeking a Project Director for the newly funded CCC and SDMC activities. This role will be classified as a staff scientist. Level and salary are commensurate with experience.
The CCC and SDMC are co-located in the Public Health Sciences Division (PHS) at Fred Hutch under two separate grants. The CCC will coordinate study operations, develop and implement communication activities, and provide trial infrastructure, including management of meetings and maintaining protocol and network guideline-related information. The SDMC will lead the statistical design, data management, analysis, and reporting for the CSRN. The Project Director will oversee and coordinate the activities of both groups.
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js');
fbq('init', '3151876674868105');
fbq('track', 'PageView');
Source link